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Synopsis The objective of this symposium at the First International Congress of Respiratory Biology (ICRB) was to
enhance communication between comparative biologists and cancer researchers working on O2 sensing via the HIF
pathway. Representatives from both camps came together on August 13–16, 2006, in Bonn, Germany, to discuss
molecular adaptations that occur after cells have been challenged by a reduced (hypoxia) or completely absent (anoxia)
supply of oxygen. This brief ‘‘critters-to-cancer’’ survey discusses current projects and new directions aimed at improving
understanding of hypoxic signaling and developing therapeutic interventions.
Introduction
Relaying minutes to hours of reduced oxygen supply
onto the level of DNA is, throughout the animal
kingdom, chiefly mediated by hypoxia-inducible
factors (HIFs). Discovered in 1995 by Wang and
Semenza as the inducing activity of erythropoietin, the
hormone that controls red blood cell production
(Wang and Semenza 1995), HIFs are now recognized
as a highly conserved family of basic-helix-loop-helix
(bHLH)/PAS (acronym for PER, ARNT, SIM, the first
proteins discovered to contain this domain) transcrip-
tion factors that confer a multifaceted adaptive
response to hypoxia via changes in gene expression.
In mammals, teleosts, the fruitfly Drosophila melano-
gaster, the crustacean Daphnia magna, and the
nematode Caenorhabditis elegans, HIF is a heterodimer
of a-subunits and b-subunits that specifically binds
target gene sequences, the so-called hypoxia-response
elements (HREs), in response to low partial pressure
of oxygen (pO2). Across all these species, declining
pO2 stabilizes and activates the regulatory a-subunit
of HIF, while physiological oxygen tensions quickly
lead to its destruction. Thus, HIF activity is con-
servedly controlled at the level of its a-subunits.
To date, three HIF-a proteins, HIF-1a/-2a/-3a, have
been reported in human and rodent cells, with the
function and regulation of the first two being far
better understood than is true for HIF-3a. All three
a-subunits, however, share the ability to hetero-
dimerize with the constitutively present HIF-1b
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subunit (Huang et al. 1996), originally known as
ARNT (aryl hydrocarbon receptor nuclear transloca-
tor), thus producing complexes HIF-1, HIF-2, and
HIF-3. As shown in Fig. 1, the HIF oxygen sensor
that controls the abundance of the a-subunits as a
function of pO2, is a family of novel prolyl
hydroxylases named PHD1-3 (prolyl hydroxylase
domain containing 1-3; Epstein et al. 2001).
As members of the 2-oxoglutarate-dependent dioxy-
genase superfamily, the PHDs catalyze the Fe(II)- and
O2-dependent hydroxylation of two specific prolyl
residues within the oxygen-dependent degradation
domain (ODD) of the HIF-1a/-2a factors (Pro402
and Pro564 in human HIF-1a). Once hydroxylated,
HIF-1a/-2a rapidly bind to the von Hippel–Lindau
(VHL) tumor suppressor protein that acts
as recognition component of an E3 ubiquitin
ligase complex, thereby tying prolyl hydroxylation
to ubiquitination and proteasomal degradation of
a-subunits under high or rising pO2 (Maxwell et al.
1999). The efficacy of this protein-level mode of
control is mirrored in cell culture by the 55 min
half-life of HIF-1a upon reoxygenation (Huang et al.
1996) and, conversely, the instantaneous accumula-
tion of the transcription factor during declining
oxygen tensions (Jewell et al. 2001). A second
O2-requiring hydroxylation, that of a single
asparagine within the C-terminal transactivation
domain of HIF-1a or HIF-2a (Fig. 1: TAD-C;
Asn803 in human HIF-1a) by an asparaginyl hydro-
xylase dubbed FIH-1 (factor inhibiting HIF-1)
leads to steric hindrance of the interaction
between a-subunits and the coactivator proteins
p300/CBP. This, in turn, prohibits the transactivation
of target genes under high pO2 (Lando et al. 2002).
The absolute requirement of PHD1–3 and
FIH-1 activities for oxygen and Fe(II) has
made these hydroxylation reactions susceptible to
inhibition by severely hypoxic and anoxic pO2. That
is why, during sufficiently low pO2, the a-subunit
is free to escape proteolytic degradation and,
assisted by accessory factors (e.g., HSP90) and/or
Fig. 1 HIF-a mediated pathway of cellular O2 sensing. Molecules are not drawn to scale. Prolyl hydroxylase in the figure represents
PHD1-3. GTF’s¼ general transcription factors of the basal machinery. For further details, see text. Figure has been previously published.
Reprinted here from Fandrey et al. 2006, with permission from the European Society of Cardiology.
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stimulatory kinase signals, to efficiently translocate
into the nucleus. Here HIF-1a/-2a dimerizes with
ARNT and the resulting ab-heterodimer associates
with transcriptional cofactors (e.g., p300/CBP),
thereby activating or suppressing target genes at
HIF binding sites (Fig. 1). Studies in hypoxia tolerant
invertebrate model systems have immensely contrib-
uted to this state of knowledge of HIF-mediated
hypoxic signaling. For example, the discovery of
mammalian PHD1-3 proteins functioning as HIF O2
sensors was made possible through the identification
of a C. elegans ortholog (EGL-9, egg-laying abnor-
mal 9) and the fact that this dioxygenase regulates
HIF function by prolyl hydroxylation in the nema-
tode in a well conserved HIF-VHL-prolyl hydroxylase
pathway (Epstein et al. 2001). Since hypoxia and
activation of HIF-1/-2 correlate with malignant
progression and poor prognosis in many cancers,
and since tumor hypoxia forms a source of resistance
to many of the current surgical, chemical, and
radiation therapies, efforts to use model organisms
for further analysis of the HIF signaling pathway
continue to grow. This 12-speaker symposium
summarized our contributions and new insights
from model organisms and human pathologies to
further elicit, integrate, and exploit incoming signals
and outgoing effects of the HIF pathway across
taxonomies and physiologies.
To set the stage, the first article by Thomas Gorr
introduced tumor hypoxia both as a concept and a
menace in today’s cancer treatments. He then
compared typical hypoxic defenses in tumors with
those of hypoxia sensitive and hypoxia tolerant,
healthy animal tissues, respectively. Next, Keith
Webster’s contribution portrayed the overall mole-
cular evolution of various hypoxia response pathways
that evolved in prokaryotes, yeasts, as well as in
multicellular plants and animals. As HIF signaling
is, thus far, exclusive for animals, this article
concluded with a brief summary of HIF’s most
widespread and, probably, primordial function: the
up-regulated expression of glycolytic enzyme genes
for an elevated substrate flux and ATP production
by anaerobe glycolysis (i.e., the Pasteur effect).
The phylogenetic section then began with two
articles dedicated to the hypoxia tolerant nematode
C. elegans. In the first of these articles, Jo Anne
Powell-Coffman presented her group’s latest findings
in support of a 2-fold regulation of hif-1, the HIF-a
homolog in the nematode, by EGL-9: (1) via the
classical VHL-dependent pathway that regulates
the oxygen-dependent degradation of the hif-1
protein (see above and Fig. 1) and (2) via a novel
VHL-independent pathway in which EGL-9 inhibits
hif-1 activity, as assayed by expression of hif-1 target
genes. Data by David Hoogewijs, on the other hand,
suggested induction of multiple C. elegans globin-like
genes under anoxia by hif-1-dependent regulation.
If confirmed, this result will, even for ‘‘lowly’’
nematodes that survive without any angiogenic or
erythropoietic components to their defensive arsenal,
dramatically underscore the importance of inducible
tissue globins (and other respiratory pigments?) in
the recovery of oxygen homeostasis after a hypoxia
assault. Moving on to crustaceans, Shinichi Tokishita
and Hideo Yamagata recently cloned the cDNAs of
the HIF-a and -b (ARNT) subunit homologs of
the cladoceran Daphnia magna. By making use
of conserved protein–protein interactions, the
D. magna HIF-a cDNA was actually isolated after a
yeast-two-hybrid screen identified its expressed
product as interactor with a D. magna ARNT bait.
The current article presents in situ evidence for tissue
specific expression patterns of Daphnia HIF-a/-b
subunits, including the presumed O2 respiring
epipodites of adult waterfleas. In contrast to
Daphnia, higher crustaceans such as decapods
express not globins but the blue, copper-containing
hemocyanins as extracellular respiratory pigments.
Nora Terwilliger’s laboratory added the complete
cDNA of the HIF-a homologue of the Dungeness
crab Cancer magister to the growing body of
invertebrate HIFs. Multiple candidate HREs in the
upstream regions of four of the six hemocyanin
genes in C. magister imply hypoxic, and possibly
even nonhypoxic, sensitivity of hemocyanin produc-
tion in decapods. The invertebrate section closed
with Thomas Hankeln’s and Thorsten Burmester’s
surprising discoveries of tissue–globin expression in
insects, a taxon that, due to the exquisite O2 supply
from trachea, was supposed not to need any diffusive
aid. Hankeln and Burmester also showed that
Drosophila expresses at least three globins, of which
the dominant glob1 is found, as yet another surprise,
to be hypoxia-suppressed in embryonic cells or
specimens. In contrast, larvae slightly elevate glob1
transcription after intermittent hypoxia. Now, we
only need to know what these globins are actually
doing in insect tissues.
Since a given volume of water contains only
1/30th of the amount of oxygen that is in the same
volume of air at the same partial pressure, and
since the rate of diffusion of oxygen in water is
10,000 times slower than it is in air, oxygen
availabilities are, as expected, far more variable and
act far more selectively during the evolution of
aquatic organisms than is the case for air breathers.
No wonder then that fishes have come forward as
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the vertebrate champions in displaying not only
extremely diverse, but also protective, adaptations to
varying degrees of hypoxia. This topic was squarely
addressed by the following two presentations.
First, Kalle Rytko¨nen and Mikko Nikinmaa reported
on their recent comparison of variation in HIF-1a
sequences amongst several fish species, which took
into account a total of eight newly determined
cDNAs. They further attempted to correlate
this variation, particularly the distribution of
redox-sensitive cysteines, with the development of
tolerance to hypoxia in these teleosts. Next, Doris
Abele, Katja Heise, and Magnus Lucassen examined
HIF activation in temperate versus cold-adapted
teleosts. Their previous work had already noted
the ‘‘early onset’’ (at higher pO2 levels) stabilization
of fish HIF-1a-proteins, relative to mammalian
factors, which had been attributed to cysteine-
enriched sequences within the ODD and TAD-C
domains. Now, they support a heightened redox-
regulation of fish HIF by contrasting increased DNA
binding under the more reducing conditions
that follow acute cold shock (temperate species)
with signs of oxidative stress and comparatively
lower constitutive levels or activities of HIF-1a
(polar species). The section on mammalian HIF
signaling was launched by the contribution by
Joachim Fandrey on live imaging of the activation
and assembly of the HIF-1 complex in hypoxic
nuclei. State-of-the-art 2-photon-laser-microscopy
and fluorescence resonance energy transfer (FRET)
techniques afforded a very high degree of resolution
and the unambiguous demonstration that, after
photobleaching, HIF-1 subunits return indepen-
dently, yet somehow coordinatedly, to the same
specific loci within the nucleus, presumed to be HRE
motifs within the chromosomes. The final two
reports gave examples of the pathophysiological
site of deranged HIF signaling in cancer.
Interestingly, both reports indicated HIF-2a, rather
than HIF-1a, to be the tumor progressing culprit.
Evidence from Patrick Maxwell’s recent work on
Ewing’s sarcoma indicated that hypoxia not only
activates angiogenesis, it also promotes vascular
mimicry by the tumor cells as well, which results
in tumor-lined channels that are linked to the
circulation and may be important in providing a
‘‘venous’’ drainage system. The clearest case in
support of HIF’s role in cancer, however, emerged
from the impressive genetic evidence that links
loss-of-function of the VHL tumor suppressor with
the commonest form of kidney cancer: clear-cell
renal-cell carcinoma. Particularly informative is VHL
disease caused by an inherited mutation in the
VHL gene. This carries a very high risk of clear-cell
kidney cancer. Following somatic ‘‘second-hit’’
inactivation of both VHL alleles, HIF-a subunits
are constitutively stabilized in large numbers of
pre-malignant foci in the kidney. As a result of HIF
activation, these foci show a markedly downregulated
expression of the intercellular adhesion molecule,
E-cadherin, which might suggest a potential mechan-
ism by which loss of VHL function could contribute
to the evolution from precancerous lesions to renal
carcinoma. An added requirement for frank tumors
to emerge in the kidney is a shift in expression from
HIF-1a to HIF-2a. Another HIF-2a driven cancer is
the childhood tumor neuroblastoma. As presented by
Sven Pa˚hlman, hypoxic neuroblastoma cells are
known to dedifferentiate by reducing expression of
neuronal markers and developing into a less mature,
more aggressive phenotype. In support of nonre-
dundant functions in this cancer, the HIF-1a subunit
was found to be transiently induced by 1% O2, while
HIF-2a gradually accumulated in mildly deprived
(5% O2) neuroblastoma cells as well as in tumor
regions adjacent to capillaries. To better comprehend
such disparate induction profiles and oxygen sensi-
tivities of the different HIF-a isoforms, future studies
need to correlate PHD and FIH specificities and
activities more closely to either subunit, and/or to
reveal additional mechanisms in control of these
transcription factors.
This concluded the cross-taxa/cross-physiology,
and most importantly, cross-boundary journey on
oxygen sensing and HIF signaling. May this ‘‘true
meeting of disciplines’’ at the ICRB 2006 inspire and
initiate fruitful exchanges and collaborations to
further enhance our understanding of hypoxic
signaling, and through it, the fight against cancer.
Trio vitale: hypoxia responses in
sensitive, tolerant, and tumorigenic
tissues (T.A. Gorr)
In contrast to the highly oxygen-dependent and
homeostatic organs and tissues of adult mammals
(Krogh 1919), most solid tumors develop regional
radiobiological hypoxia as they accumulate mass
(Thomlinson and Gray 1955). Since vascular beds in
neoplasms are generally comprised of immature,
disarrayed, and poorly functional capillaries, the
tumor will ultimately outgrow vessel-to-cell oxygen
diffusion distances that can range from 50 to
230 mm (Tannock 1968, 1972). The resulting breach
of O2 supplies (low) and demands (high) triggers a
severely limited and extremely heterogeneous oxyge-
nation of the tumor tissue with oxygen partial
Hypoxia signaling, from critters to cancer 555
pressures (pO2) frequently 55 mmHg ( 0.7% O2)
[reviewed by Vaupel et al. (1998) and Brown and
Wilson (2004)]. Several groups recently elucidated
metabolic shifts in O2-deprived cancer cells that go a
long way towards understanding the multifaceted
resistance by which human tumors can cope with
these erratic and, at times, completely lacking
supplies of oxygen, glucose, and other blood-born
nutrients [reviewed by Ho¨ckel and Vaupel (2001),
Wouters et al. (2004), and Feldman et al. (2005)].
Curiously enough, these tumor adaptations appear to
recapitulate main paradigms that previously had
emerged as the quintessential defense of hypoxia
tolerant invertebrates, ectotherms, and neonatal or
hibernating endotherms. Inspired by these concep-
tually novel contributions by noted physiologists to
tumor biology (Hochachka et al. 2002), this article
will continue down their ‘‘critter-to-cancer’’ linking
path through a brief review of tumor hypoxia and its
correlation with the prevailing safeguards against low
pO2’s in three existing frameworks: (1) hypoxia
sensitive, healthy (¼nontransformed) tissues; (2)
hypoxia tolerant, healthy tissues, and (3) hypoxia
tolerant, transformed tissues.
Tumor hypoxia manifests itself on many levels.
It renders transformed cells more radio-resistant,
promotes their growth through angiogenesis and
increases the odds for local recurrences, metastasis
or genetic lesions. It also is known to select for
the expansion of apoptosis-defying cell variants
[reviewed by Semenza (2003), Vaupel (2004),
Maxwell (2005), and Zhou et al. (2006)]. In short:
a low oxygen microenvironment drives malignant
progression towards a more invasive, therapy-resis-
tant phenotype. Many, if not most, of these adverse
changes during human tumorigenesis are conferred
by altered gene expression profiles that are mediated
through the oxygen sensing response pathway of the
hypoxia-inducible factors 1 and 2 (HIF-1 and HIF-2)
[reviewed by Semenza (2003), Vaupel (2004),
Maxwell (2005), and Zhou et al. (2006)]. Due to
scarcity in oxygen supply, and/or hyperactive onco-
genic upstream signals, HIF’s regulatory
subunits (HIF-1a, HIF-2a) are frequently over-
expressed in multiple malignancies as opposed to
undetectable levels in healthy, oxygenated tissues.
Consequentially, HIF-1a/-2a protein abundance can
serve for many, but not all, cancers as independent
prognostic marker for disease progression and poor
clinical outcome. Thanks to global research efforts of
the past decade, we are now able to unquestionably
link tumor hypoxia and the subsequent activation of
HIF-1/-2 signaling to the specific reprogramming of
cellular fates and physiology, whereby, on
balance, the tumor’s survival and growth is pro-
moted. Cellular transformation is, however, not
the only way to acquire stress resilience. Many
invertebrate, and some lower vertebrate, species
are similarly endowed to withstand and recover
from otherwise lethal limitations in oxygen avail-
ability. Of note in this context, the pioneering
work of Hochachka, Boutilier, and many others,
which laid down the unifying principles of stress
defenses in tolerant animal models, (Hochachka
1986; Hochachka et al. 1996; Boutilier 2001),
also had a tremendous impact on studies regarding
the role of hypoxia in the genetic underpinnings
of tumor development (Murphy 2004).
Oxygen tensions in normal tissue (e.g., skeletal
muscle), unlike those in tumors, are, even under
the most extreme work loads, in a near-perfect supply/
demand homeostasis (reviewed by Hochachka 1999).
This exquisite equilibrium between metabolite delivery
and metabolic output works well across a wide range of
pO2. As long as ambient oxygen tensions exceed a
critical threshold (pC), usually occurring at a tension
of1.8–18 mmHg (0.2–2% O2) (Rumsey et al. 1990;
Arthur et al. 1999; Gnaiger 2003), the mitochondrial
electron flux is substrate saturated and proceeds at or
near its maximal velocity. Thus, O2 uptake and the
ensuing oxidative metabolism function more or less
independently from supplies (Gnaiger 2003). Upon
chronic (minutes–hours) declines of tissue pO2 to
near-pC levels, however, the typical array of physiolo-
gical responses during fetal and adult stages of
mammalian development include hypoxia-induced:
(a) erythropoiesis (production of red blood cells);
(b) angiogenesis (development of new blood vessels
from pre-existing ones);
(c) vasodilation (lumen widening due to relaxation of
smooth muscles in vessel wall);
(d) high-flux glycolytic carbohydrate consumption
(the Pasteur effect);
and, upon further deprivation of oxygen:
(e) initiation of apoptotic (programmed) or necrotic
(accidental) pathways of cell death.
With currently several hundred potential (Manalo
et al. 2005) and 70 validated hypoxia-responsive gene
targets (Wenger et al. 2005), including those for
critical erythropoietic or angiogenic growth factors
and nearly all glycolytic enzymes, oxygen sensing via
HIF-1/-2 signaling is clearly the key in controlling
each one of the above defense categories in healthy
tissues (reviewed by Schofield and Ratcliffe 2004;
Semenza 2004; Fandrey et al. 2006). As hallmarks of
hypoxia sensitive mammalian organs (e.g., brain,
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kidney, and liver) (Duffy et al. 1972; Suarez et al.
1989), the earlier-listed energy compensating
strategies function to either keep vascular O2-carrying
capacities steady (a–c), or, at least for brief periods
of time (seconds–minutes), to maintain preexisting
rates of ATP demand during periods of dwindling
oxidative ATP synthesis (d). Upon HIF-mediated
induction of the genes that launch the Pasteur
effect [see Webster 1987; Iyer et al. 1998;
Seagroves et al. 2001; Stubbs et al. 2003; Webster
2003 and Webster (subsequently)], however, this
high-flux glycolysis quickly depletes finite stores of
fermentable substrate (e.g., glycogen) and amasses
toxic levels of end products (e.g., Hþ per ATP
hydrolysis) in sensitive, hypoxic cells. In the absence
of energy expending reductions, anaerobe fermenta-
tions fail to meet ATP maintenance demands of
ionic and osmotic equilibrium, and are thus unable
to prevent an ultimately fatal ATP imbalance in
central neurons, renal tubular cells, or hepatocytes
(Duffy et al. 1972; Buck and Hochachka 1993;
Hochachka et al. 1996; Krumschnabel et al. 2000;
Boutilier 2001).
Hypoxia tolerant animal models, on the other
hand, predominantly rely on energy conserving
strategies that center around a stress-induced and
stress-maintained, yet fully reversible, suppression of
the metabolic rate (hypometabolism) (reviewed by
Gorr et al. 2006a). This metabolic suppression down
to a newly balanced ATP supply¼ATP demand
steady-state, prevents lethal falls in cellular ATP
levels and is the single most protective and unifying
feature of nontransformed hypoxia tolerant tissues
(Hochachka et al. 1996; Boutilier 2001). The lower
the ATP turnover can be suppressed, the longer the
cells remain protected during hypoxic or anoxic
challenges (Guppy and Withers 1999; Krumschnabel
et al. 2000). To match the synchronously declining
ATP production in O2-depleted cells, hypometabo-
lism requires the immediate and coordinated down-
regulation of every major ATP-utilizing function in
the cell, including (1) protein synthesis and degrada-
tion; (2) ion-motive ATPases, notably Naþ/Kþ-
ATPase; and (3) gluconeogenesis (Rolfe and Brown
1997). Therefore, the large-scale drop in protein
turnover (Land et al. 1993; Land and Hochachka
1994) and ion-motive pump activities maintain, as a
tolerance hallmark, electrochemical gradients across
membranes at reduced permeabilities (channel arrest)
(Buck and Hochachka 1993; Krumschnabel et al.
2000). As further advantage of hypometabolic states,
glycolytic fluxes only need to be elevated and provide
for ATP as much as the residual energy expen-
ditures require (i.e., weak-absent Pasteur effect)
(Storey 1985; Grieshaber et al. 1994; Schmidt and
Kamp 1996). Hence, entry into a hypometabolic state
spares fermentable fuel, reduces metabolic waste and
extends survival time. Along with hypometabolism,
cells also enter a state of quiescence due to a slowing
down, or complete blockade, of cell cycle pro-
liferation from defined hypoxia-sensitive check-
points. Finally, since 80% of mitochondrial
O2-consumption is coupled to ATP synthesis (Rolfe
and Brown 1997), transitions into anaerobiosis and
metabolic depressions are indicated by proportion-
ally declining oxygen consumption rates. Particularly
tolerant systems show extended oxygen-dependent
respiration even under mild hypoxia (Po¨rtner and
Grieshaber 1993; Gnaiger 2003). This so called
oxyconformance is characterized by O2 uptake rates
that decline proportionally with ambient pO2.
It contrasts with the regulated respiration of most
cells in culture, where the rate of O2 uptake remains
constant and independent of pO2 across a wide range
of oxygen tension. Mechanistically, the switch from
oxyregulated to oxyconforming respiration is, in
mammalian cells at least, also orchestrated via HIF-1.
During pO2 pC, the HIF-1-induced pyruvate
dehydrogenase kinase 1 (Pdk1) inhibits pyruvate
dehydrogenase from using pyruvate to fuel the
mitochondrial tricarboxylic acid (TCA) cycle.
This TCA block was recently shown to actively
suppress respiration, redirect both O2 and glucose
utilization towards cytosolic sinks, and rescue cells
from hypoxia-induced apoptosis (Kim et al. 2006;
Papandreou et al. 2006; Simon 2006).
Tumors typically survive conditions of ‘‘little’’ or
‘‘no’’ oxygen through a mixed repertoire of energy-
compensating and energy-conserving defenses,
respectively. As established by Folkman and col-
leagues, tumors depend on the process of angio-
genesis for growth beyond a few millimeters in
size and for subsequent spreading to other sites
(reviewed by Hanahan and Folkman 1996; Carmeliet
and Jain 2000). However, angiogenetic capacities and
competence vary greatly among types of tumors.
Pronounced angiogenetic switches are known to
occur in rapidly proliferating, metabolically active
cancers of the brain (e.g., glioblastomas) and kidney
(e.g., renal cell carcinomas), less so in mammary
carcinomas, and least in lung and prostate carcino-
mas (Eberhard et al. 2000). Moreover, oxyregulated
respiration of cancer cells is commonplace and
reveals critical thresholds ranging from 0.15% O2
for Ehrlich ascites cells (Froese 1962) to 1.5% O2
for neuroblastoma cells (Robiolio et al. 1989).
Respiratory and metabolic switches, it seems, occur
with corresponding oxygen sensitivities in normal
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and neoplastic tissues. Along similar lines, cultured
aerobic cancer cells are not inherently more glyco-
lytic than are normal ones, as transformed and
nontransformed cells alike partition their total
normoxic ATP production into 80% oxidative
and 20% glycolytic contributions (Guppy et al.
2002; Zu and Guppy 2004). Rather than being
causally linked with tumorigenesis, these data
reinforce that prominent glycolysis only reflects
active proliferation (Brand and Hermfisse 1997)
and/or exposure to low pO2 (above) of any kind of
cells (discussed by Stubbs et al. 2003). However,
near-anoxic cancer cells (Ebbesen et al. 2004) and
perinecrotic layers in spheroids or experimental
tumors can also adapt to diffusion-limited nutrient
supplies via energy-conserving strategies of metabolic
depression and quiescence. ‘‘Critter-like,’’ these
cancer cells halt growth (reviewed by Giaccia 1996),
reduce O2 consumption rates and, thus, efficiently
alleviate local gradients of hypoxia. They lower ATP
consumption by (1) inhibiting DNA replication,
(2) inhibiting the majority of mRNA and protein
syntheses, and (3) arresting cell cycle proliferation at
a single G1/S (hypoxic pO2) transition point or
multiple (anoxic pO2) transition points (reviewed by
Ho¨ckel and Vaupel 2001). ‘‘Critter-Unlike,’’ our
information to date is wholly inadequate in regard
to relative changes of activities and ATP demands on
ion pumps (e.g., Naþ/Kþ-ATPase) to generally assess
if, and how, whole-cell membrane currents and ion
transport are maintained in O2-deprived neoplasms
(but see, Wodopia et al. 2000; Karle et al. 2004).
In contrast, several groups have recently made strides
towards discerning the molecular mechanisms by
which hypoxic/anoxic cancer cells downregulate O2
consumption (i.e., HIF-1/Pdk1 switch, mentioned
earlier) and mRNA translation (Wouters et al. 2003,
2004; Feldman et al. 2005).
The greatly simplified classification of hypoxia
responses in Fig. 2 shows for transformed cells and
solid tumors an overall mixed pattern of adaptations,
whose individual aspects will vary with the type or
stage of tumor, the host microenvironment and the
severity of hypoxia. One way for gaining tolerance
that seems unique to tumors (Fig. 2) is the hypoxia-
mediated selection of apoptosis-resistant cell variants
that acquired mutations in apoptosis-triggering
tumor suppressor genes such as p53 (reviewed by
Wouters et al. 2004; Zhou et al. 2006). Indicated
through the intersection with hypoxia sensitive
physiologies, the energy compensating hypoxia
responses in tumors are, at least in part, inherited
from the hypoxia-sensitive precursor tissue, yet can
certainly be modified and exaggerated. This ‘‘first
line of defense’’ is induced by more or less moderate
hypoxia (i.e., pO2 0.15–1.5% O2 ﬃ pC) and
includes the HIF-mediated activation of angiogenesis
along with a variably strong Pasteur effect. During
severe O2 limitation (i.e., pO2  pC), transformed
and malignant cells defend themselves by an
immediate switch into O2-conforming respiration
(Fig. 2) and entrance into energy-conserving hypo-
metabolic and quiescent stages (intersection to
hypoxia tolerant responses). Intervening with these
tolerance-conferring defenses which, physiologically,
set the tumor apart from its hypoxia-sensitive host
organ, holds great potential for more selective cancer
diagnostics and therapies (Wouters et al. 2003, 2004;
Feldman et al. 2005). In contrast, intervening with
anaerobe glycolysis will, as a more or less ubiquitous
response, affect transformed and healthy hypoxic
tissues alike. Unfortunately, relative to angiogenetic
or glycolytic switches, the existence of hypometa-
bolic, quiescent states in hypoxic cancer cells and
tumors has yet to emerge as mainstream tenet within
the oncological community. It is here where
resilient ‘‘critters’’ with sequenced genomes such
as C. elegans, Drosophila, zebrafish, and others to
Fig. 2 Venn diagram of different hypoxia responses. Tumor
responses in general consist of a mixed pattern with some
defensive components derived from the hypoxia sensitive
precursor tissue (regular text), while others emerged as newly
developed defenses that gain the tumor a measurable degree of
hypoxia tolerance (italic text). Evading apoptosis seems to be a
defense unique to progressing oncogenesis (boldface type).
Intersecting areas in the diagram symbolize great variability in
the overlaps between three response categories. Controlled
regulations: process induced: arrow tilted up; process maintained:
horizontal arrow; process suppressed: arrow tilted down;
uncontrolled insult of process: cross; bold arrows: strong
response; thin arrows: weak response.
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follow (e.g., Daphnia) can help pave the way for
characterizing, and eventually blocking, key players
and pathways that underlie tolerance to hypoxia in
human pathologies.
Molecular evolution of the regulation
of glycolytic enzyme genes by hypoxia
(K.A. Webster)
Life evolved on earth for about 2 billion years under
anaerobic conditions, close to one half of the total
time period of biological evolution (Barnabas et al.
1982; Papagiannis 1984). Therefore, the fundamental
features of biology and genetics, including DNA
synthesis, transcription, translation, and their regula-
tion were established under anaerobic conditions
(Segerer et al. 1985). Perhaps because of this, certain
proteins, pathways, and regulatory processes function
preferentially under hypoxia. This is particularly true
for glycolysis, where oxygen regulates both enzyme
activity and gene expression (Webster 1987; Webster
et al. 1990). The regulation involves contributions
from at least four separate molecular pathways, some
of which may have been conserved through 4 billion
years of evolution dating back to the anaerobic
origin of life. There are numerous molecular
modulators of glycolytic flux, the most famous of
which was reported by Louis Pasteur (1861).
He showed that oxygen inhibited fermentation and
that glucose consumption was inversely proportional
to oxygen availability, i.e., that glycolysis was
positively regulated by hypoxia (Pasteur effect)
(see Gorr earlier). Over a century later, in 1987,
our group reported that the expression of multiple
glycolytic enzyme genes was also coordinatedly
regulated by oxygen tension, and that there was a
reciprocal effect on the transcription of some
mitochondrial genes (Webster 1987; Webster et al.
1990). Whereas the Pasteur effect was probably a
rather early acquisition in the regulation of glycolysis
by oxygen tension, the control of gene expression by
hypoxia appears to have evolved gradually and
possibly in a series of stages. Figure 3 illustrates
some of the DNA sequence elements that may have
been involved in the evolution of this regulation.
Oxygen-regulated gene switching in bacteria and
archaea includes the activation and/or repression of
genes and operons of key metabolic enzymes (Bunn
and Poyton 1996). This includes positive and
negative factors regulated by oxygen tension or
redox potential and involves contributions of at
least three major regulatory pathways, including
the ARC, FNR, and CSRA–CSRB systems.
Features of the ARC and FNR systems suggest that
they may be the predecessors of the hypoxia
regulation of eukaryotic glycolytic enzyme genes.
The ARC system is involved in the repression of
aerobic functions under anaerobic conditions,
whereas the FNR system is involved in the anaerobic
induction of metabolic enzyme genes (Bunn and
Poyton 1996). FNR, like HIF-1a, is a transcription
factor with redox-regulated cysteine residues that
determine conformation and DNA binding (see
Abele et al. subsequently). The target sequence for
activated FNR includes the consensus sequence
nTTGATnnnnATCAAn, which is a typical palindro-
mic binding site for helix-turn-helix motifs common
to many mammalian transcription factors, including
HIF-1. This is perhaps the earliest example of a
redox-regulated helix-turn-helix transcription factor
involved in the regulation of bioenergetic genes. Yet,
there are even closer parallels between these regula-
tory pathways and those that regulate glycolytic
enzyme genes in higher mammals. In the yeast,
Saccharomyces cerevisiae, the OLE1 gene encodes a
delta9 fatty acid desaturase that is essential for the
synthesis of unsaturated fatty acids. OLE1 is induced
by hypoxia, transition metals, and iron chelators. An
element in the OLE1 gene promoter with the
sequence ACTCAACAA is responsible for the
response to hypoxia. This element named LORE
(low oxygen responsive element) can confer hypoxia
inducibility to a heterologous promoter and binds a
Archaea/Bact TTGATnnnnATCAAn H-T-H binding motif
Yeast/Fungi ACTCAACAA  ? LORE
Monocotyledons TGGTTT HRE
GC(G/C)CC HRE
Mono/Dicotyledons
CC(C/G)GC HRE
Arabidopsis CCACGTGC SRE
Insects - Mammals ACGT HIF
AP-1
TGATTC      
Sp1
GGGCCC
3B
Y
Fig. 3 Evolution of hypoxia response elements of glycolytic
enzyme genes. The earliest oxygen response element is found in
archaebacteria and bacteria; the sequence resembles a classical
helix-turn-helix (H-T-H) DNA binding motif and binds the factor
FNR. The low oxygen response element (LORE) of yeast binds a
protein that is activated by hypoxia and transition metals
reminiscent of the later HIF-1 pathway. Hypoxia response
elements (HREs) and stress response elements (SREs) of plants
have sequences that resemble AP-1, Sp1, and HIF-1 sites, each of
which can function as hypoxia responsive elements in insects, fish,
and mammals.
Hypoxia signaling, from critters to cancer 559
specific hypoxia-inducible protein. Additional LORE
elements have been identified in the promoters of
other hypoxia-inducible genes, suggesting a mechan-
ism for a global synchronized response to hypoxia in
S. cerevisiae. This may be the earliest evidence of a
regulatory system capable of mediating a global
response of multiple unlinked genes to changes in
oxygen tension. Although the sequence of the LORE
does not resemble any identified mammalian LORE
(Fig. 3), the common responses of S. cerevisiae
LOREs and mammalian HREs to hypoxia, transition
metals and iron chelators suggest related pathways
(Vasconcelles et al. 2001; Jiang et al. 2001b).
Exposure of maize root cells to hypoxia results in
the induction of approximately 20 proteins, deemed
anaerobic polypeptides (Dennis et al. 1988; Olive
et al. 1991; Dolferus et al. 1994). Two anaerobic
response elements (ARE) were identified in the
proximal promoters of the aldolase and ADH1
(alcohol dehydrogenase1) genes. The first site con-
tained the consensus sequence TGGTTT and the
second site contained the consensus GC(G/C)CC
(Olive et al. 1991). Mutation of these elements
resulted in the loss of response to hypoxia. Further
studies revealed the specific binding of a protein to
the GC-rich element and this protein was designated
GCBP-1 (GC-rich binding protein-1). This protein
has not been fully characterized; its abundance is not
changed by hypoxia, it requires accessory proteins
and/or posttranslational modifications to mediate
transcriptional activation by hypoxia, and its binding
to the GC site is in competition with members of the
SP1 family of zinc finger transcription factors. There
are strong parallels between this regulatory pathway
and that described recently for the regulation of
mammalian muscle-specific pyruvate kinase (PKM)
and b-enolase genes (Discher et al. 1998). These
elements represent the earliest examples of hypoxia
response elements directly controlling individual
glycolytic enzyme genes. Plants also provide a clue
as to how hypoxia response elements were selected
from other stress response pathways of regulation,
including temperature and osmolarity, both of which
featured significantly as evolutionary selective pres-
sures. Hypoxia, dehydration, and hypothermia
induce the ADH gene in the roots of the dicotyledon,
Arabidopsis thaliana. The promoter contains a single
GT/GC motif, which has a similar sequence to the
Zea mays GC site, except that the GT motif is in
reverse orientation (Dolferus et al. 1994). The
Arabidopsis ADH promoter contains a second
motif with the sequence CCACGTGC. The core
sequence of this motif, ACGTG, is the binding site
for HIF-1, the major hypoxia regulatory binding
protein in mammalian cells (see above and Fig. 1).
Interestingly, this motif appears to be required for
ADH gene induction by hypothermia, dehydration,
and UV light, but not hypoxia, whereas the hypoxia
response is determined by the GT/GC sequence.
The regulation of glycolytic enzyme genes by
hypoxia in nematodes, insects, crustaceans, fish,
reptiles, birds, and mammals and possibly all
mobile multicellular species is multifactorial, with
clear origins in the prokaryotic and fungal regulatory
systems (Webster and Murphy 1988; Hochachka and
Lutz 2001). Animal glycolytic enzyme genes are
regulated both coordinatedly and individually by
hypoxia-responsive transcription factors including
HIF-1, SP-1 family factors, AP-1, and possibly
metal response elements (Murphy et al. 1999).
HIF-1 is probably the main component and is
largely responsible for coordinating the induction
(Webster et al. 2000; Webster 2003). The core
consensus sequence for HIF-1 binding is ACGT,
and active HIF-1 binding sites have been reported in
at least eight glycolytic-enzyme genes, usually in the
proximal promoter regions (reviewed by Wenger
et al. 2005).
In conclusion, HIF functions in nematodes,
insects, crustaceans, and vertebrates but not in
plants or fungi, and it is possible that the pathway
developed in the Silurian period about 500 million
years ago, when highly mobile metazoans were
evolving. The sequence ACGTC is essential, although
not sufficient, for gene activation by HIF-1. The
same sequence is required for the hypothermia,
dehydration, and the UV response of Arabidopsis
genes involved in carbohydrate metabolism. It seems
likely that this recognition sequence, and the protein
that binds it, are related in plants and animals, and
thus may provide the link between gene regulation in
hypoxic root tips and the HIF-1 pathway seen from
‘‘worm to man’’ (Webster et al. 2000).
Genetic analysis of hypoxia signaling
and response in C. elegans
(J. A. Powell-Coffman)
Regulation of HIF-1 protein levels by the EGL-9
enzyme and the VHL tumor suppressor is evolutio-
narily conserved. The C. elegans homologs of the
HIF-1a and HIF-1b subunits are hif-1 and aha-1,
respectively (Powell-Coffman et al. 1998; Epstein
et al. 2001; Jiang et al. 2001a). The majority of the
transcriptional responses to hypoxia require hif-1
function, and hif-1 loss-of-function mutants fail to
adapt to hypoxia, yet thrive in normoxia and are able
to survive anoxia-induced arrest (Jiang et al. 2001a;
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Padilla et al. 2002; Shen and Powell-Coffman 2003;
Shen et al. 2005). Caenorhabditis elegans is amenable
to both forward and reverse genetic approaches,
and it is an immensely powerful model system
for gene discovery and characterization of genetic
networks (Jorgensen and Mango 2002; Gunsalus and
Piano 2005). The egl-9 encodes a member of the
2-oxoglutarate-dependent oxygenase superfamily
(Darby et al. 1999; Aravind and Koonin 2001).
When oxygen levels are sufficiently high, EGL-9
hydroxylates HIF-1. The C. elegans ortholog of the
von Hippel–Lindau tumor suppressor, VHL-1, then
targets HIF-1 for degradation (Epstein et al. 2001)
(see above and Fig. 1). There are three mammalian
homologs of EGL-9, and they are termed PHD,
HPH, or EGLN genes (Bruick and McKnight 2001;
Epstein et al. 2001; Ivan et al. 2002).
The C. elegans egl-9 clearly has functions inde-
pendent of vhl-1. The C. elegans egl-9 gene was
originally isolated as a gene required for normal
egg-laying (Trent et al. 1983). More recently, egl-9
mutants have also been shown to have decreased
sensitivity to cyanide (Gallagher and Manoil 2001).
The vhl-1/ mutants have not been shown to have
either of these defects. Bishop et al. (2004) showed
that while egl-9 RNAi increased expression of a HIF-
1 target gene in a vhl-1 mutant, the dioxygenase
inhibitor 2,20-dipyridyl (DIP) did not. This suggested
that some egl-9 functions may not require prolyl
hydroxylation of HIF-1. The Powell-Coffman group
compared the vhl-1/ and egl-9/ phenotypes
more extensively, and determined that, while HIF-1
target genes are expressed at much higher levels
in egl-9 mutants, HIF-1 protein is expressed at
similar levels in vhl-1- and egl-9-defective animals
(Shen et al. 2006). Collectively, these data are
consistent with a model in which EGL-9 acts via
two pathways to regulate HIF-1 function: (1) EGL-9
hydroxylates HIF-1 and targets it for VHL-1-
dependent degradation; (2) EGL-9 acts via a
second VHL-independent pathway to inhibit HIF-1
expression or activation, and this pathway may not
require EGL-9 hydroxylase activity (Fig. 4) (Shen
et al. 2006).
The Powell-Coffman group has also developed
genetic screens to identify and characterize HIF-1
regulatory networks in C. elegans, and they have
isolated several ‘‘rhy’’ mutations (regulators of the
hypoxia-inducible factor). Mutations in the rhy-1
gene cause over-expression of HIF-1 target genes and
morphological defects that are similar to those
exhibited by egl-9 mutants. These defects are
suppressed by a loss-of-function mutation in hif-1.
Expression of HIF-1 target genes is higher in
rhy-1(ok1402); vhl-1(ok161) double mutants than
in single mutant and this suggests that RHY-1 and
VHL-1 act via two independent pathways in limiting
expression of these HIF-1 targets. The rhy-1(ok1402)
mutation causes a slight increase in hif-1 mRNA
(1.8-fold) and HIF-1 protein (2.2-fold) levels. This
increase in HIF-1 protein levels is smaller than
that caused by loss-of-function mutations in vhl-1 or
egl-9 (which over-express HIF-1 protein 4.8-fold and
4.5-fold, respectively). These data are consistent
with a model in which RHY-1 has a minor effect
on HIF-1 protein expression and functions
primarily in a VHL-1-independent pathway to limit
HIF-1 function (Fig. 4) (Shen et al. 2006).
Important questions for future studies include:
How does RHY-1, an integral membrane protein,
inhibit expression of HIF-1 target genes?
What proteins or pathways interact with RHY-1 to
regulate HIF-1 function? Do similar proteins
regulate mammalian HIF?
Quantitative expression analysis of
C. elegans globins under anoxic
conditions (D. Hoogewijs)
The genome of C. elegans encodes at least 33 putative
globins (Hoogewijs et al. 2004; Vinogradov et al.
2006). Their sequences all align with the classical
globin fold composed of eight helices (A–H), and,
consistently possess the invariant proximal histidine
Fig. 4 Model for regulation of C. elegans HIF-1 by multiple
negative feedback loops. When oxygen levels are high, the EGL-9
enzyme hydroxylates HIF-1. This covalent modification allows
VHL-1 to target HIF-1 for degradation. Genetic data in C. elegans
show that EGL-9 also inhibits HIF-1 activity via a separate,
VHL-1-independent pathway. Additionally, C. elegans RHY-1
functions in a negative feedback loop to inhibit HIF-1 function.
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at position F8 (i.e., the eighth residue in the F-helix).
All putative C. elegans globins have orthologs in the
sibling species C. briggsae and C. remanei and some
display significant similarity in sequences with
BLASTP Expect (E) values ranging from e02 to
e12 to vertebrate myoglobin, neuroglobin, and
cytoglobin (the E-value describes the number of
expected hits that occur by chance for similarly
scoring matches between the query and a database
entry). Comparison of all globin-like sequences
revealed major differences in genome organization,
gene structure, and expression profiles (Hoogewijs
et al., submitted for publication). Phylogenetic
analysis has shown that the majority of these globins
are highly divergent from each other, indicative of
long and independent evolutionary histories
within the gene family (Hoogewijs et al. 2004).
Preliminary analysis of spatial expression suggests
that many of the C. elegans globins are expressed
in tissue-specific patterns. Evaluation of their
relative abundance using real-time quantitative
PCR (qPCR) experiments shows, moreover, that
all globin genes are transcribed at low level in
wild-type adults, except T22C1.2 and ZK637.13
which are expressed more prominently.
To investigate which globins might be regulated in
response to oxygen deprivation, synchronized young
adult worms (1–2 days of adult age) were exposed to
anoxic conditions (50.001 kPa O2) for 12 h and the
changes in levels of gene expression relative to
normoxia were analyzed by qPCR. Results demon-
strate a robust 2–5-fold upregulation for several
globin genes under anoxic conditions (Table 1).
To verify whether the elevated transcription of
these globin-like genes is regulated by HIF, qPCR
experiments were performed in age-synchronized
adult hif-1 mutants. In support of a widespread
HIF-1 control of globin synthesis, eight out of
10 putative globins were no longer induced by
anoxia in hif-1 mutants (Table 1). Additional
support for a HIF-1/globin link in C. elegans, as
also seen in Daphnia (see Tokishita and Yamagata
subsequently) or Drosophila (see Hankeln and
Burmester subsequently), came from a computa-
tional analysis of globin genomic regions that
detected the presence of putative HREs in all
anoxia-induced globin genes. These globins are also
induced under normoxia in hif-1 mutants (data not
shown), however, suggesting more complex, and
possibly HIF-independent regulations that might
compensate for the loss of HIF-1 function. More
questions emerged upon realizing that anoxic worms
arrest development along with cell-cycle progression
and enter a reversible state of suspended animation
for which HIF-1 function is not required
(Padilla et al. 2002; Shen and Powell-Coffman
2003). It thus appears that hypoxia responses via
HIF-1 are activated as the pO2 drops below a
threshold, and may extend, for at least some
genes, even into anoxia. Further, experimental
evidence is needed to discern hypoxic from anoxic
inductions of C. elegans globins and to understand
why HIF-1, albeit being dispensable for anoxic
survival, still regulates target genes during extreme
O2 deprivation.
Globin gene expression was additionally evaluated
in mutants of the daf-2 insulin/insulin-like
growth factor receptor homolog of C. elegans. daf-2
mutants are known to be hypoxia resistant
(Scott et al. 2002). The daf-2 pathway regulates
development and life-span in nematodes, whereby
a reduction in signaling is transduced onto down-
stream targets through activation of the DAF-16
forkhead transcription factor that produces an
extended life-span and elevated stress resistance.
Results of qPCR amplifications have shown that,
following anoxia, nearly all globin genes are
expressed at lower levels in daf-2 mutants compared
to wild-type worms. In contrast, ZK637.13, the
first detected globin species in C. elegans (Mansell
et al. 1993), is significantly induced (4-fold),
possibly indicating an insulin-like pathway depen-
dent regulation (Hoogewijs et al., submitted
for publication). Interestingly, expression of
ZK637.13 was demonstrated only in a subset of
epidermal cells (Lynch et al. 1995). RNAi experi-
ments are ongoing to ascertain whether ZK637.13
is required for resistance to oxygen deprivation
of daf-2 worms.
Table 1 Differential globin expression in wild-type and hif-1
mutant worm under normoxia and anoxia
Globin gene Wild-type A/N hif-1 A/N
F21A3.6 2.248 1.074
Y17G7B.6 2.118 1.121
C26C6.7 5.574 0.919
R13A1.8 2.024 1.056
W01C9.5 1.958 1.007
C18C4.9 2.538 1.192
Y75B7AL.1 1.897 1.144
C36E8.2 2.279 0.929
T22C1.2 2.247 1.116
C18C4.1 2.572 0.957
The figures represent fold differences in expression of at least three
independent biological repeats (Hoogewijis et al., Submitted for
publication). A¼ anoxia, N¼ normoxia. P50.05.
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Expression of HIF and hypoxic induction
of hemoglobin in the crustacean
Daphnia magna (S. Tokishita and
H. Yamagata)
We previously found four genes for hemoglobin
(Hb) chains constituting a compact cluster on the
chromosome of D. magna (Kimura et al. 1999). Our
recent analysis showed that at least six Hb genes
(dhb1–dhb6) constitute that cluster. All genes consist
of seven exons and six introns; i.e., they all encode
a di-heme domain, 31 kDa globin subunit.
All intergenic regions within the cluster contain
numerous candidate HREs that are homologous to
the binding sites of mammalian HIF-1 (see above
and Fig. 1). Gorr et al. (2004a) showed that HREs
located upstream of the dhb2 gene interact in vivo
and in vitro with human and Drosophila HIF
complexes, and with the presumed Daphnia HIF
complex, in response to hypoxia. To elucidate
whether the structure of the HIF complex and
overall features of HIF signaling pathway are
conserved between mammals and Daphnia, we
cloned D. magna cDNAs that encode the HIF-a
and HIF-b (ARNT) subunits.
By screening a D. magna cDNA library with DNA
probes that were amplified from conserved regions in
ARNT genes of various organisms, cDNAs encoding
a D. magna homolog of ARNT were isolated and the
structural and functional features, as well as the
expression pattern of their product, DmagARNT,
were analyzed (Tokishita et al. 2006). Among known
bHLH-PAS proteins, the deduced amino-acid
sequence of DmagARNT showed the highest
degree of identity to that of Drosophila ARNT
(aka TANGO). Expression of DmagARNT in
ARNT-lacking mouse Hepa-c4 cells fully recovered
the loss of hypoxia response, suggesting the forma-
tion of a functional heterodimer with mouse HIF-1a
and the subsequent transactivation of the down-
stream luciferase reporter.
DmagARNT was produced in an Escherichia coli
expression system and then used to immunize rats.
Whole-mount immunostaining of D. magna embryos
was performed with the aid of an antibody
thus raised against DmagARNT. Expression of
DmagARNT was evident at the middle to late
stages of embryonic development (about 25–48 h
after ovulation) in several tissues, including a pair
of the 1st antenna, 2nd antenna, 2nd maxilla, five
pairs of the thoracic limbs, the central nerve system,
anus, dorsal organ, maxillary gland, and carapace.
As observed in other species, the DmagARNT is
likely to function broadly as expressed dimerization
partner in various developmental and sensory
processes. In contrast, expression of ARNT in adult
D. magna was limited to the epipodites of thoracic
limbs, suggesting that ARNT plays a role solely in the
hypoxia response in adult Daphnia.
A traditional cDNA library screening, as used
for the cloning of D. magna ARNT, failed to
identify a cDNA for D. magna HIF-a. Therefore, a
yeast two-hybrid system was employed using an
upstream half of a cDNA for D. magna ARNT
fused with GAL4-DNA binding domain as bait.
A D. magna cDNA library fused with GAL4-
activation domain was used as prey. A cDNA for
D. magna HIF-a was found among the GAL4-
positive clones. Alignment of the amino acid
sequence encoded by the cloned D. magna HIF-a
cDNA with those of other organisms showed a
high degree of sequence conservation of bHLH and
PAS domains. Two proline residues within the
oxygen-dependent degradation domain, hydroxyla-
tion of which leads to proteosomal degradation
of the protein (see above and Fig. 1), are conserved
in D. magna HIF-a. On the other hand, an
asparagine residue in the C-terminal transactivation
domain, hydroxylation of which leads to hindrance
of interaction with the coactivater p300/CBP
(see above, and Fig. 1), is not conserved in
D. magna HIF-a. This TAD-C asparagine residue,
therefore, is present in HIF-a’s of decapodan
crustaceans, amphibians, fish, and other vertebrates,
while it is missing in those of Daphnia, Drosophila,
and C. elegans. The mechanisms that activate the
HIF complex may thus be different between the
former and latter, and one might speculate that
prolyl-hydroxylation and a-subunit degradation
phylogenetically preceded the transcriptional inacti-
vation under high pO2 via asparagine hydroxylation.
Phylogenetic analysis of the conserved bHLH
and PAS domains, however, showed the expected
close relationships of cladoceran, decapodan, and
Drosophila HIF-a polypeptides. Whole-mount
immunostaining was carried out on D. magna
embryos using an antibody prepared against
D. magna HIF-a. Hypoxia-induced expression of
HIF-a was observed in several tissues including
epipodites, a presumed respiratory organ (Fig. 5).
HIF-1 regulation in crustaceans
(N.B. Terwilliger)
Hypoxic conditions in coastal waters around the
world, resulting primarily from pollution runoff,
are a global problem that threatens the wellbeing
of numerous marine organisms (Diaz 2001).
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Oceanic waters in the Northeastern Pacific are
normally oxygen rich due to a combination of
extensive upwelling of cold, nutrient-rich waters, and
strong northwest winds that blow surface waters
away from the coast in a counterclockwise direction.
For the past five summers, however, a large region of
oxygen-poor water has formed off Oregon’s coast,
probably due to shifting wind patterns, and large
numbers of dead crabs and fish have been reported.
In August 2006, a 30-mile ‘‘dead zone’’ containing as
little as 0.1 ml oxygen per liter seawater wreaked
major destruction on marine organisms in Oregon
oceanic waters. Thus, not only coastal but oceanic
organisms are subject to the effects of hypoxia.
In addition to these severe episodes, the challenge
of responding to normal tidal fluctuations in
oxygen levels extends to marine organisms living
in rocky intertidal pools and estuaries. It is, there-
fore, of major interest to understand what role HIF
might play in the response of marine crustaceans
to environmental stressors, including hypoxia.
In the phylum Arthropoda, HIF has been des-
cribed in one group of Crustacea, the Branchiopoda,
and in the Insecta. Branchiopod crustaceans, includ-
ing Daphnia, Artemia, and Triops, increase hemoglo-
bin (Hb) synthesis after hypoxic exposure (Fox 1948;
Kobayashi and Tanaka 1991; Terwilliger 1992). HREs
have been identified in the upstream regions of all
globin genes (i.e., dhb1–dhb6) of Daphnia magna
(see Tokishita and Yamagata earlier). Some of the
motifs located in the 50 flank of the dhb2 gene were
found to be essential in conferring HIF-mediated
transactivation during hypoxia onto a heterologous
reporter (Kimura et al. 1999; Gorr et al. 2004a).
The sequences of both HIF cDNA’s have recently
been described in D. magna (see Tokishita and
Yamagata earlier). Interactions between HIF and
globin synthesis have also been described in insects
(Hankeln et al. 2002; Gorr et al. 2004b; Hankeln and
Burmester subsequently). Prompted by these earlier
reports, we started to examine the role of HIF in
regulating gene expression in the blue-blooded
Malacostraca, the large group of crustaceans includ-
ing crabs and shrimp that typically express copper-
containing hemocyanin rather than Hb (Terwilliger
1998).
To this end, we determined the complete cDNA
sequence of a HIF-a homolog in Cancer magister, the
Dungeness crab (Ryan, Terwilliger, and Head,
Genbank #DQ535030). The sequence aligns well
with alpha subunit homologs from other arthropods,
the grass shrimp Palaemonetes pugio, the
fly Drosophila melanogaster, and the honeybee Apis
mellifera. The sequence from C. magister also shows
good alignment with those of chordate species,
including the fish Oncorhyncus mykiss, the amphibian
Xenopus laevis, and human Homo sapiens. The
sequence from C. magister includes the bHLH
region, the PAS A and B domains, the ODD, and
the C-terminal activation domain, regions conserved
in HIF sequences from other phyla (Fig. 1). The total
length of the HIF-a proteins shows distinct phylo-
genetic differences, however. Among the Arthropoda,
insect HIF-a‘s are longer (D. melanogaster: HIF-a
homolog SIMA, 1505aa; A. mellifera, 1576aa) than
those of crustaceans (C. magister, 1047aa; P. pugio
1057aa). The HIF-1a sequence in Chordata is even
shorter (X. laevis 802aa, H. sapiens 826aa, and
O. mykiss 766aa). These differences in length reflect
major insertions and/or deletions in concert with
conservation of key functional domains.
Increases in concentration and oxygen affinity
of hemocyanin have been reported in response
Fig. 5 Tissue specific expression of D. magna HIF-a at the late
stage of embryonic development following exposure to hypoxia
(3% O2, 20h). Whole mount embryos were subjected to
fluorescent immunostaining with a rat antibody raised against
D. magna HIF-a. Fluorescent signals were visualized by a confocal
laser scanning microscope (Leica TCS SP2). Hypoxia-induced
expression of D. magna HIF-a was observed in epipodites of
the thoracic limbs at the late stage of embryonic development.
Ep1–Ep 5, epipodites on the five thoracic limbs.
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to hypoxia and/or hyposalinity in several
crustacean species, including Carcinus maenas,
Nephrops norvegicus, and Callinectes sapidus (Boone
and Schoffeniels 1979; Baden et al. 1990; Mangum
1997). These changes suggest that synthesis of
hemocyanin, like that of the extracellular Hbs of
branchiopod crustaceans, might be regulated by
hypoxic, nonhypoxic, and possibly even develop-
mental stimuli (Rider et al. 2005; Gorr et al. 2006b).
The genes coding for six hemocyanin subunits of
C. magister have been sequenced (Ryan and
Terwilliger, manuscript in preparation) and the
upstream regulatory regions have been examined
for putative HIF-binding sites. Multiple consensus
(RCGTG) and core (CGTG) sequences in the
upstream regions of four of the six genes and in
the intergenic region between linked hemocyanin
genes 1 and 2 are present, consistent with a role for
HIF-1 in the regulation of hemocyanin synthesis.
Three of these genes code for constitutive hemocya-
nin subunits 1, 2, and 3, whereas the gene for
hemocyanin subunit 6 is developmentally regulated
(Terwilliger et al. 2006).
The ODD region of a HIF-a homolog in the blue
crab Callinectes sapidus has recently been amplified
using primers based on the HIF sequence of
C. magister. These results illustrate the conserved
nature and broad expression of HIF in brachyuran
crustaceans.
Globins in Drosophila and other insects:
respiratory proteins, oxygen scavengers,
or else? (T. Hankeln and T. Burmester)
Respiratory proteins in insects have long been
considered a specialty of taxa that regularly encoun-
ter hypoxic conditions in their habitats (reviewed by
Burmester and Hankeln 2007). Notable examples are
the aquatic mud-dwelling larvae of nonbiting midges
(chironomids). Their extracellular globins, encoded
by an unusually large gene family of more than
40 genes (Hankeln et al. 1998), account for more
than 90% of the larval hemolymph proteins. Thus,
their function is the storage and transport of oxygen,
facilitating survival even under almost anoxic condi-
tions. Larvae of the horse botfly (Gasterophilus
intestinalis) also survive in the hostile environment
of the horse alimentary tract by extracting oxygen via
intracellular globins, mainly expressed in tracheal
cells and the fat body (Dewilde et al. 1998).
Backswimmers (Insecta: Notonectidae), diving pre-
dators that breathe under water with the aid of an
abdominal air bubble, have intracellular globins at
high concentration in a specialized ‘‘tracheal organ.’’
The oxygen bound by the globins is used to
replenish the air bubble at later stages of the dive,
thus maintaining neutral buoyancy (Matthews and
Seymour 2006).
Globins have been totally unexpected in those
insects which have almost unlimited access to oxygen
via their tracheal system. Our survey of available
sequence databases, however, revealed the presence
of globin genes in various Diptera, Hymenoptera,
Lepidoptera, Hemiptera, and Coleoptera. Thus, globins
are a natural and ubiquitous constituent of the insect
gene repertoire. While being phylogenetically more
diverse than anticipated, all these insect globins
feature the sequence hallmarks necessary for rever-
sible oxygen-binding and probably localize to the
cytoplasm. On the tissue level, a common theme is
their expression in cells of the tracheal system, as
demonstrated experimentally in Drosophila, the
honeybee, and mosquitoes (Hankeln et al. 2002,
2006; Burmester et al. 2007). Other prominent globin
expression sites like the fat body, visceral muscles,
testes, or malpighian tubules were also observed,
depending on the species and the developmental
stage.
In Drosophila, three globin genes have been
identified (Burmester and Hankeln 1999; Burmester
et al. 2006). glob1 is the most prominently expressed
globin, found in the tracheal system and fat body in
embryos, larvae and adults. Potential HREs are
conserved in glob1 from various Drosophila species,
suggesting potential upregulation of this gene after
hypoxia. However, glob1 mRNA levels did not
change in adult Drosophila melanogaster after experi-
mental hypoxia, and were even diminished by about
50% in embryos and larvae. This is in agreement
with in vitro cell culture data, suggesting a transcrip-
tional downregulation of glob1 via the HIF system
(Gorr et al. 2004b). Slightly increased glob1 expres-
sion (1.5-fold) in larvae was observed only after
hypoxia/normoxia cycles and following hyperoxia
(95% O2). These data can be unified to suggest that
glob1 preferentially fulfils the role of a regional O2
buffer in tracheal cells, either supplying oxygen at
peaks of most intensive oxidative metabolism, or
binding excessive O2 during periods of rest, in order
to prevent the accumulation of toxic reactive oxygen
species.
Evolution of HIF-1a in fishes
(K.T Rytko¨nen and M. Nikinmaa)
Oxygen has been a major force in evolution of
aquatic organisms, including fishes (Val 1995;
Farmer 1999; Janis and Farmer 1999; Chapman and
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Hulen 2001; Nikinmaa 2002; Powell 2003; Nikinmaa
and Rees 2005). Oxygen availability is a more critical
environmental factor for aquatic animals than for
terrestrial ones, since at the same partial pressure,
water contains only 1/30th of the oxygen contained
in the same volume of air. Moreover, the rate of
diffusion of oxygen in water is only 1/10,000 of that
in air (Dejours 1975). As there are both phylogen-
etically closely related fishes with differing oxygen
requirements and distantly related species with
similar oxygen requirements, fishes are the primary
choice among vertebrates for comparative evolu-
tionary studies of oxygen-dependent systems.
We investigated whether sequence variation in the
HIF-1a gene associates with oxygen demand among
several fish species, including novel HIF-1a
sequences from protacanthopterygian, cypriniform,
and perciform lineages. Our results indicate that the
HIF-1a genes of teleost fishes are somewhat shorter
than are those of tetrapods (see Terwilliger earlier).
We inspected the variation in specific amino acid
residues and concentrated especially on redox-
sensitive cysteines that are involved in signaling by
reactive oxygen species (ROS) (Barford 2004), and
consequently also by oxygen levels. Initially, it was
found that human HIF-2a, but not HIF-1a, function
is modulated by redox reagents (Lando et al. 2000).
Partially, this effect is due to a serine–cysteine
substitution in the DNA binding basic region of
the bHLH feature. Human HIF-2a has a cysteine at
position 25, which aligns with a serine at position 28,
in mammalian HIF-1a. Site-directed mutagenesis of
Ser28 of mammalian HIF-1a to Cys28 conferred
redox sensitivity to DNA binding (Lando et al.
2000). Studies in salmonid cells revealed that DNA
binding of some fish HIF-1a is also regulated by
redox state (Nikinmaa et al. 2004). Cloning of the
rainbow trout HIF-1a sequence showed indeed
the presence of a cysteine at position 28 (Soitamo
et al. 2001), while in the hypoxia tolerant cyprinids,
HIF-1a position 28 is occupied by serine.
In correspondence with HIF sensitivities, ROS
appear, at least in some cases, to be involved in
mediating oxygen sensitivity (Bogdanova and
Nikinmaa 2001). For these reasons, we set out to
correlate variation in HIF-1a sequence with hypoxia
defense strategies in fishes: i.e., does HIF-1a of
hypoxia tolerant species generally have Ser28 and is
this residue a cysteine in hypoxia sensitive species.
Careful sequence analysis demonstrated, however,
that position 28 is occupied by cysteine in the
hypoxia tolerant Protacanthopterygii (pike), as is the
case in the hypoxia sensitive salmonids, and by
serine in the hypoxia tolerant cyprinids, whereas the
hypoxia sensitive asp possesses an asparagine in this
location. Thus, the presence or absence of cysteine
in HIF-1a position 28 does not appear to correlate
with species specific hypoxia defense strategies but
rather may reflect phylogeny.
On the other hand, the most notable group-
specific variation was found in the vicinity of
Asn-803 (human HIF-1a nomenclature). As pre-
viously shown, 15 amino-acid residues before, and 20
after, Asn-803 in human HIF-1a appear to be
important for FIH activity (Koivunen et al. 2004).
The alignment of our data set (Fig. 6) shows that
positions 11 to þ20 (with regard to Asn-803) are
well conserved in all vertebrates, with some group-
specific exceptions. The most notable of these are the
Ostariophysi/Cypriniformes-specific amino-acid resi-
dues in the þ5 and þ7 positions after Asn-803.
Ostariophysi have aspartic acid (D) in position þ5,
whereas other vertebrates have glycine (G) instead.
In position þ7 Cypriniformes have histidine (H),
whereas other vertebrates have arginine (R) or
glutamine (Q). Substituting glycine (G) for aspartic
acid (D) in position þ5 introduces an extra negative
charge, and the presence of histidine makes the
charge variable within the physiological pH range.
Fig. 6 Alignment of the C-terminus of the HIF-1a amino acid
sequence of available fish species and selected other species.
Cysteine 800, Asparagine 803 (human HIF-1a nomenclature), and
positions þ5 and þ7 upstream from Asparagine 803 are marked
with arrows. In these positions, Ostariophysi (black line) and
Cypriniformes (white line) have lineage-specific amino acid
residues. Ostariophysi have aspartic acid (D) in position þ5,
whereas other vertebrates have glycine (G) instead; in the þ7
position Cypriniformes have histidine (H), whereas other verte-
brates have arginine (R) or glutamine (Q). The figure is similar to
the original one published in Rytko¨nen et al., (2007). Reproduced
here with the permission from Elsevier.
566 D. Hoogewijs et al.
It remains to be investigated whether these
group-specific amino acid changes are correlated
with the generally good hypoxia resistance of
Ostariophysi/Cypriniformes.
To summarize, no clear HIF-1a signatures could be
associated with hypoxia tolerant versus sensitive
phenotypes. If species-specific differences in oxygen
dependence of HIF-1a function have evolved, they
probably occur at other levels of the HIF-1a pathway.
HIF and cold adaptation in fish
(D. Abele, K. Heise and M. Lucassen)
Hypoxia tolerant champions like the crucian carp,
which survive long winter months under a fully
closed ice cover, exhibit constitutive HIF-a protein
levels in various central organs and gill tissue. Short
term hypoxic exposure further elevates HIF-1a
protein levels in the crucian carp, especially at low
water temperature, which presumably supports
hypoxic survival during winter cold (Rissanen et al.
2006). Recently, constitutive HIF-1a expression was
also confirmed in less tolerant, and even hypoxia
sensitive, fish like the North Sea eelpout, Zoarces
viviparus (Heise et al. 2006b) and its polar con-
familial Pachycara brachycephalum from Antarctic
deep waters, where environmental hypoxia is unlikely
to occur (Heise et al., 2007, in press).
To specify changes in HIF-1a gene structure and
HIF pathway functioning that may relate to cold
adaptation in marine fish, we compared partial
cDNA sequences of different cold-adapted species,
covering the C-terminal half of HIF-1a from North
Sea and Antarctic eelpout, as well as from two
Antarctic nototheniids and the icefish Chionodraco
myersi. Stabilization of HIF-1a at much higher pO2
in fish cells (i.e., 5–10% O2 ﬃ 38–76 torr) than in
mammalian cells has been attributed to the exchange
of up to four amino acids of the human sequence for
redox-sensitive cysteines in the ODD of rainbow
trout (Soitamo et al. 2001) and both zoarcid
(position of ZvHIF-1a: 442, 496, 512, 578) ODD
regions. All Antarctic fish investigated, thus far,
carry three cysteine-yielding exchanges in the
ODD and two additional cysteines in, or next to,
the C-terminal transactivation domain (Fig. 1),
which could be important in conferring an
increasingly redox sensitive HIF transactivation
mechanism (Nikinmaa et al. 2004). Cysteine
exchanges in HIF-1a sequences from marine and
fresh water fish reported to date support the idea
that HIF-dependent gene control might be very
sensitive to redox regulation within the normoxic
(i.e., noncritical) pO2 range, hence illustrating a clear
difference between the pathway controls of fish and
mammals.
The cellular redox environment is strongly deter-
mined by the glutathione redox ratio GSH/GSSG
(i.e., reduced/oxidized glutathione) that rapidly
destabilizes once environmental or physiological
stressors trigger an unbalanced formation of reactive
oxygen species (ROS). To examine the direct impact
of the redox potential (EmV) on HIF function, we
heat-shocked (12!18, 22, 268C) and cold-shocked
(12!5, 18C) North Sea eelpout for 2 h and
measured HIF binding to the human erythropoietin
enhancer in gel shift assays of liver extract. Figure 7A
shows the direct correlation between a reduced redox
potential with lowered ambient temperatures for
eelpout liver (heat shock 245 mV, control
260 mV, cold shock 275 mV), whereas Fig. 7B
indicates a significant linear relationship between an
increase of HIF-DNA binding and a reducing redox
potential in Zoarces viviparus liver (Heise et al.
2006a, 2006b).
Comparing fish from different latitudes (Antarctic
eelpout versus North Sea eelpout) at their natural,
low, water temperatures (08C for the polar and 68C
for the temperate eelpout), we found different
levels of oxidative stress indicators and different
glutathione contents. Antarctic eelpout maintain
oxidative stress indicators in liver, specifically the
lipid peroxidation marker TBARS (thiobarbituric
acid reactive substances) and chemiluminescence
rates, indicative of singlet oxygen formation and
oxidative stress in general (Gonzalez Flecha et al.
1991), at significantly lower levels than do North
Sea eelpout. Cellular glutathione content was sig-
nificantly increased (3-fold) in the polar eelpout
over North Sea eelpout and, moreover, oxidized to
GSSG by over 50%. Although EmV did not differ
significantly (P¼ 0.13) between these two species,
HIF–DNA binding in gel shift assay was significantly
lower in the polar than in the temperate fish.
Furthermore, antibodies newly produced against
the eelpout HIF-1a detected lower constitutive
HIF-1a protein levels in the polar species (Heise
et al., 2007, in press). Taken together, both findings
are in line with a lower hypoxia tolerance of the
cold-adapted Antarctic species. Similar to the geo-
graphic cold adaptation in the Antarctic fish,
seasonal cold acclimatization of temperate eelpout
(summer T: 128C and winter T: 68C) was associated
with an oxidation (P50.01) of cellular EmV.
North Sea eelpout, however, accumulated higher
levels of oxidative damage indicators (protein
carbonyls and TBARS) in liver tissue during the
winter season. Yet, as in acutely cold shocked
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eelpouts (Fig. 7B), HIF–DNA binding increased
significantly in liver extracts of winter Z. viviparus,
in spite of the more oxidized redox conditions.
Thus, in these eurythermal fish, either other
signaling components overwrite the oxidizing
cellular milieu in favor of an elevated HIF-1/DNA
binding during the winter cold, or the transcription
factor response to the cellular redox signal is
somehow changed or desensitized in response to
winter acclimatization. Another possible explanation
for this conundrum is that protein turnover
and removal of peroxidized lipids is slowed in the
cold, resulting in higher tissue concentrations of
oxidative damage markers, without necessarily
requiring higher rates of ROS production.
We conclude that seasonal, as well as evolutionary,
cold adaptation leads to more oxidized redox
conditions, and only maintenance of high antiox-
idant defence levels seems to offset oxidative damage
in liver tissue of cold-adapted fish. HIF-1 DNA-
binding is lowered, possibly by reactive oxygen
species production during heat shock. Whereas HIF
seems to be involved in seasonal cold acclimatization
in eurythermal eelpout, lower HIF protein levels and
DNA-binding capacity of the transcription factor in
the stenothermal Antarctic species may, in part,
explain the comparably lower tolerance to hypoxia
and generally higher stress susceptibility of the
Antarctic fish. Future studies need to scrutinize a
possible role of HIF during the cold adaptation
of fish when there is no temperature-induced
tissue hypoxia.
Imaging the activation and assembly
of the mammalian HIF-1 complex
(J. Fandrey)
Imaging the components of the oxygen sensing
mechanisms is difficult. We have previously localized
the nuclear distribution of HIF-1a and of the
O2-sensors PHD1, PHD2, PHD3, and FIH-1
(Metzen et al. 2003; Berchner-Pfannschmidt et al.
2004). While the localization of HIF-1a and HIF-1b
in hypoxic nuclei has been unambiguously shown by
many groups, it is not clear when dimerization of
the two partners actually occurs. Models so far are
based on co-immuno-precipitation studies but not
on imaging within living cells. Moreover, crystal-
lization of full length HIF-a’s and HIF-1b, or even
the entire HIF-1 complex, to obtain information
about potential structural changes within the com-
plex upon transition from normoxia to hypoxia,
and vice versa, has not been successful thus far.
Partial crystal structures of the PAS domain B, which
is present in HIF-a’s and HIF-1b (Fig. 1), were
recently unraveled (Card et al. 2005). It was
proposed that, within the HIF-1 complex, the PAS
B domains of HIF-1a and HIF-1b are oriented in
an antiparallel manner to form the HIF-1 dimer.
This is unusual with respect to other members
of the PAS family (Yildiz et al. 2005), and
Fig. 7 (A) Cellular redox potential as a function of temperature. The cellular redox potential was calculated on the basis of the
GSH/GSSG ratio at in situ temperature and in situ intracellular pH (Schafer and Buettner 2001) in liver samples of Zoarces viviparus
after 2 h cold exposure to 1 and 58C (unstressed fish at control temperature 128C), as well as after 2 h heat exposure to 18, 22,
and 268C. Each dot represents an individual fish sample, ¼ significantly different from the unstressed group at 128C, P50.05.
(B) HIF-1 activity as a function of cellular redox potential. Linear regression demonstrating increased HIF-1 DNA binding at a
more reduced redox environment (R2 ¼ 0.3, n¼ 50, P50.05, Statview 5.0).
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Card et al. (2005) pointed out that it needed to be
shown how the active HIF-1 complex is formed in
the nucleus of living cells.
To measure the mobility of HIF-1 subunits by
fluorescence recovery after photobleaching (FRAP),
we constructed HIF-1a-ECFP (enhanced cyan fluor-
escence protein) and HIF-1b-EYFP (enhanced yellow
fluorescence protein) fusion proteins and determined
their nuclear distribution in the human osteosarcoma
tumor cell line U2OS by 2-photon-laser-microscopy.
Subnuclear structures of heterogeneously distributed
HIF-1 subunits were reliably detected. Interestingly,
return of fluorescence after photobleaching led to the
recovery of exactly the same subnuclear structures,
indicating that HIF-1 subunits were directed to
specific loci within the nucleus, i.e., putative sites of
HRE binding. Moreover, we found different velocities
whereby HIF-1a and HIF-1b returned into the
bleached areas to recover fluorescence. This was
unexpected because, until now, it was assumed that
HIF-1a, upon entering the nucleus, immediately
forms the dimer with HIF-1b. Our data clearly
indicate that both subunits can move independently
of each other and thus do not immediately associate
inside the nucleus. To obtain even more detailed
information about the geometry of the HIF-1 complex
in living cells, we established FRET with different
HIF-1a-ECFP fusion proteins as donor molecules and
HIF-1b–EYFP as acceptors. We were able to unam-
biguously show close interaction of HIF-1a and
HIF-1b under hypoxic conditions in living U2OS
cells, using HIF-1a/b fusion proteins labeled at
their N-terminal ends. The distance between the two
HIF-1 subunits of only 6.6 nm was derived from
calculations from FRET efficiencies determined over a
range of acceptor/donor ratios. HIF-1a and HIF-1b
labeled at their N-termini were found to be fully
transcriptionally active which disproved the concern
that the N-terminal ECFP/EYFP labels might impede
DNA binding. When both HIF-subunits were labeled
at their C-terminus, the distance between the HIF-1
subunits was 7.2 nm, which is fully compatible with
the notion that co-activator proteins like p300/CBP
are bound to the C-terminus (Fig. 1). Unexpectedly,
using a HIF-1a–ECFP C-terminal deletion
mutant that lacks the TAD-C of HIF-1a, HIF-1a,
and HIF-1b, distances were only moderately closer.
Surprisingly, the distance between the C-terminally
labeled HIF-1a and N-terminally labeled HIF-1b
determined by FRET was only 7.9 nm, indicating that
the C-terminus of the HIF-1 complex is much closer
to the DNA binding domains than was previously
thought (Wotzlaw et al. 2007). This could facilitate
interaction with other tissue-specific transcription
factors (Fig. 8). Our data are fully compatible
with partial X-ray structure analyses of the PAS B
domains of HIF-a’s, suggesting an antiparallel
orientation of the PAS B domains and thus a
more compact assembly of the HIF complex
(Card et al. 2005).
Hypoxia-inducible factor and cancer
(P.H. Maxwell)
There is extensive documentation of hypoxia in
cancers compared to normal tissues. This is due to
inefficient delivery of oxygen via a less robust
vascular network, and also because proliferating
tumor cells are metabolically active. Hypoxia is an
important prognostic indicator. Not only do hypoxic
tumors respond less well to chemotherapy and
radiotherapy, but outcomes are also worse if they
are managed surgically. Since HIF-1 is activated by
hypoxia this suggested that HIF could play a role in
cancer biology and might be important in aspects of
Fig. 8 Putative conformation of the HIF-1 dimer based on distance
calculations derived from FRET measurements. The HIF-1 dimer is
schematically drawn (not to scale!) with its bHLH domains bound to
the DNA at the HRE (see Fig. 1 for orientation). Labeling HIF-1a
with ECFP and HIF-1b with EYFP at their N-terminal ends results in
a distance of 6.6 nm between the two fluorophores. PAS A and PAS
B domains are shown in an anti-parallel orientation of the PAS B
domain which results in a rather close proximity, i.e., 7.9 nm, of the
C-terminal transactivation domain (TAD-C) of HIF-1a, labeled with
ECFP, to the EYFP-labeled N-terminus of HIF-1b. The coactivator
p300/CBP may thus come close to the DNA-bound other
transcription factors.
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the tumor phenotype such as angiogenic signaling
and enhanced glycolysis (see Gorr earlier).
Insight into the potential role of the HIF system in
tumor biology has come from examining the
behavior of model tumors grown from cells with
genetic alterations in the HIF pathway. For example,
we showed some years ago that xenografts of mouse
hepatoma cells lacking HIF-1b do not show focal
expression of the HIF target genes VEGF (vascular
endothelial growth factor) and GLUT1 (glucose
transporter 1), are less well vascularized and grow
more slowly than do isogenic HIF-competent tumors
(Maxwell et al. 1997). As expected for a pathway
with extensive downstream targets, the net results on
tumor growth vary from one cell background to
another. At least in part, this is because HIF also
activates expression of proapoptotic genes such as
BNIP3 (BCL2/adenovirus E1B 19 kDa interacting
protein 3). This illustrates that natural selection in
a population of tumor cells could result in increased
activity of a pathway with positive and negative
consequences for cellular proliferation and survival—
as long as the overall balance was positive.
If increased HIF activation results in increased
survival through metabolic changes, a number of
neutral or deleterious effects of HIF could be co-
selected. Particular interest has focused on the role of
HIF activation in angiogenic signaling by tumors.
An interesting new twist is that, with Dr Griffioen,
we have shown that hypoxia results in vascular
mimicry in Ewing’s sarcoma (van der Schaft et al.
2005). As a result, blood channels are formed that
are directly lined by tumor cells having many
features normally associated with endothelial cells.
Intriguingly, these channels appear to provide a
route for deoxygenated blood to leave the tumor.
Although much is known about how tumors increase
blood inflow, an obvious consequence is that more
drainage will be required. It is interesting to
speculate that HIF activation will have a general
role in coordinating this venous drainage.
Strong support for the importance of HIF in
cancer biology comes from studies showing that
HIF-1a subunits are commonly expressed in human
tumors, whereas they are not generally detectable in
normal tissue (Harris 2002). Increased HIF activation
generally correlates with a poor prognosis. In some
tumor series, however, the reverse has been seen,
which is consistent with HIF defective tumors
growing more rapidly in some experimental studies.
More direct evidence for a role of HIF in driving
the initiation and promotion of tumors is that
cancer-associated mutations in tumor suppressor
genes and oncogenes commonly increase HIF
activation. The clearest example to date is VHL.
This is a classic two-hit tumor suppressor
gene originally isolated from studies of kindreds
with the multitumor autosomal dominant syndrome
characterized by von Hippel and Lindau about
100 years ago. VHL acts as the recognition
component of an ubiquitin E3 ligase enzyme that
captures HIF-1a/2a subunits in the presence of
oxygen, leading to their ubiquitination and destruc-
tion (Fig. 1). In the absence of VHL, HIF a-subunits
are stabilized and are constitutively active.
Complexity is added by the fact that VHL inactiva-
tion almost certainly has other consequences that are
independent of HIF activation. We are particularly
interested in two linked questions. First, how does
inactivating VHL result in the initiation of tumors?
Second, what are the consequences of genetic
activation of HIF in normal human tissues? One
route we have pursued was to examine tissues from
humans with VHL disease due to a germline
mutation in the VHL gene. Labeling the cell-surface
enzyme carbonic anhydrase IX (CAIX), another
strongly responsive HIF target, provides a robust
way of identifying groups of cells that have a somatic
‘‘second hit’’ so that both VHL alleles are inactivated
(Mandriota et al. 2002). Several interesting findings
have emerged. In kidneys from VHL patients these
foci of HIF activation are common, but show
minimal evidence of increased proliferation com-
pared to adjacent cells. Nevertheless, they show many
hallmark features of clear cell renal cell carcinoma,
including expression of the intermediate filament
vimentin, increased angiogenesis, and a clear cell
appearance. Recently, we have used these foci to
show that HIF activation results in another hallmark
feature of cancer—a striking decrease in expression
of the intercellular adhesion molecule, E-cadherin.
Furthermore, re-expression of VHL or antagonizing
HIF in renal cancer cells with defects in VHL rescues
E-cadherin expression (Fig. 9) (Esteban et al. 2006).
Interestingly, the earliest lesions of VHL inactivation
identified on the basis of CAIX only express HIF-1a.
Progression to cysts, and to frank tumor, is
associated with expression of HIF-2a in addition to
HIF-1a, suggesting that additional genetic events that
produce a shift to dominant expression of HIF-2a
are important in tumor development in the kidney.
Consistent with this, expressing HIF-1a into 786-O
renal cancer cells (which usually only express
HIF-2a) reduces their growth as xenografts. In
renal cancer cells, and in the premalignant lesions,
there are distinct consequences of HIF-1 and HIF-2
activation. For example, cyclin D1 is increased by
HIF-2 exclusively, whereas CAIX and BNIP3 are only
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increased by HIF-1 (Raval et al. 2005). Interestingly,
the situation is different in spinal cord, where our
studies with Dr Vortmeyer (NIH) have shown that
the earliest foci of VHL inactivation express only
HIF-2 (Vortmeyer et al. 2006). While CAIX is an
exclusive HIF-1 target in the kidney, in spinal cord
lesions expression of HIF-2 in isolation appears
sufficient to activate CAIX. This illustrates that the
isoform selectivity of HIF activation varies in
different cell types, and that the downstream linkages
also show cell-type specificity.
Effect of hypoxia on neuroblastoma
phenotype and behavior. Molecular
mechanisms and clinical consequences
(S. Pa˚hlman)
The childhood tumor neuroblastoma is derived from
immature or precursor cells of the sympathetic
neuronal lineage (Hoehner et al. 1996, 1998;
De Preter et al. 2006). The clinical behavior of
neuroblastomas is notoriously heterogeneous and
ranges from benign (ganglioneuroma) to highly
aggressive (neuroblastomas with amplification of
the oncogene MYCN that encodes N-Myc) lesions,
and in general, less mature neuroblastomas are more
aggressive than are more differentiated forms.
Hypoxia has been shown to be one cause of
phenotypic heterogeneity, and recently we observed
that hypoxic neuroblastoma cells reduce their expres-
sion of neuronal differentiation marker genes and
become stem cell-like (Jogi et al. 2002). A similar
loss of differentiation characteristics was also seen
in hypoxic breast cancer cells (Helczynska et al.
2003) and we conclude that loss of differentiation
adds to the general pattern of hypoxic tumor
cells being more aggressive than are more well-
oxygenated ones.
Cellular adaptation to hypoxia is to a large
extent mediated by stabilization of the hypoxia-
inducible transcription factors HIF-1a and HIF-2a.
These factors are also important during normal
development in general. More specifically, HIF-2a is
implicated in the development of the sympathetic
nervous system (SNS) (Tian et al. 1998).
Consistently, HIF-2a is specifically expressed in
mouse embryonic and human fetal SNS structures
(Tian et al. 1998; Jogi et al. 2002; Nilsson et al. 2005)
and high HIF-2a expression, observed in
seemingly well-vascularized neuroblastomas, might
be explained by their SNS origin (Holmquist-
Mengelbier et al. 2006). HIF-1a could not be
detected in these HIF-2a positive neuroblastoma
cells, and in vitro growth of neuroblastoma cells at
21%, 5%, or 1% oxygen revealed that HIF-2a, but
not HIF-1a, becomes stabilized and is active at 5%
oxygen. We could further show that VEGF, as one of
several classical hypoxia-driven genes, is already
expressed at 5% oxygen via a HIF-2a-dependent
process, which prompted us to conclude that HIF-2a
acts as an oncogene at least in neuroblastoma.
To address that issue, both HIF-a isoforms were
transiently knocked-down in neuroblastoma cells
and injected subcutaneously in nude mice. The
resulting tumors grew more slowly when HIF-2a
expression was reduced, while HIF-1a level reduction
had no impact on tumor growth (Holmquist-
Mengelbier et al. 2006). In a large clinical study
on neuroblastoma material, we could demonstrate
a correlation between HIF-2a protein levels and
VEGF expression and even more importantly,
a correlation between high HIF-2a protein expres-
sion and poor patient outcome. We conclude
that HIF-2a in neuroblastoma cells is active at
near-physiological oxygen concentrations and
transcribes genes linked to a bona fide hypoxic
phenotype, which could explain the association
between high HIF-2a protein expression and aggres-
sive neuroblastoma behavior.
Fig. 9 The VHL-HIF pathway regulates expression of the cell
adhesion molecule E-cadherin in renal cells. Immunofluorescence
images for E-cadherin showing that the VHL defective renal cell
cancer line, RCC10, expresses little or no E-cadherin (top left).
DAPI-stained nuclei are visible as distinct ovals throughout the
figure. Stable expression of a VHL gene rescues E-cadherin
expression (top right). The siRNA for HIF-1a and HIF-2a also
rescues E-cadherin expression (bottom right). Figure courtesy of
Dr M. Esteban and Ms S. Harten.
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Conclusion
The ‘‘worm-to-man’’ survey on oxygen sensing
via HIF presented here spans a wide variety of
taxa and highly divergent physiological frameworks
(i.e., hypoxia sensitive, hypoxia tolerant, healthy,
and neoplastically transformed). Studying HIF in
model invertebrates such as C. elegans, Drosophila,
and Daphnia has the advantage that many of the key
players in this pathway (e.g., HIF-a, PHD, and VHL)
are each encoded by single-copy genes. As the genetic
redundancy is diminished, the in vivo functional
analysis of these pathway members via the generation
of knockdown or mutant phenotypes is greatly
facilitated and simplified. Furthermore, HIF signaling
is remarkably conserved across the animal kingdom,
which is commonly being exploited for the design of
experimental protocols to clone and characterize
novel HIFs and downstream targets from related
species (see above). Possibly the biggest asset of
characterizing hypoxia responses in these model
invertebrate and lower vertebrate ‘‘critters,’’ however,
is their unparalleled tolerance towards even the most
severe limitations in oxygen. Due to that, defenses in
a nematode, a fly or a carp and those of a solid
human tumor, resemble one another in fundamental
aspects (see above). The fact that C. elegans or
Drosophila are genetically tractable to the (1) analysis
of, and (2) interference with, hypoxia tolerance on
a genome-wide scale has already begun, and
will certainly continue, to have a great impact on
tumor biology through the improved
understanding of the molecular mechanisms under-
lying hypoxia tolerance, and the development of
new diagnostic markers and therapeutic targets
of the HIF pathway.
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